HEALTHY VOLUNTEERS SICKLE CELL DISEASE, THALASSEMIA
Clinical trials for HEALTHY VOLUNTEERS SICKLE CELL DISEASE, THALASSEMIA explained in plain language.
Never miss a new study
Get alerted when new HEALTHY VOLUNTEERS SICKLE CELL DISEASE, THALASSEMIA trials appear
Sign up with your email to follow new studies for HEALTHY VOLUNTEERS SICKLE CELL DISEASE, THALASSEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Big meal vs. empty stomach: scientists test drug absorption
Knowledge-focused CompletedThis study tested how eating a high-fat meal affects the way a new drug called etavopivat gets into the bloodstream. Sixteen healthy adults took a single dose of the drug twice—once after a big meal and once on an empty stomach—to compare the results. The goal was to gather basic…
Matched conditions: HEALTHY VOLUNTEERS SICKLE CELL DISEASE, THALASSEMIA
Phase: PHASE1 • Sponsor: Novo Nordisk A/S • Aim: Knowledge-focused
Last updated Apr 02, 2026 07:41 UTC
-
Safety check: does new blood disorder drug mix safely with common meds?
Knowledge-focused CompletedThis study tested whether a new drug called etavopivat, being developed for sickle cell disease and thalassemia, changes how the body processes five common medications. Thirty-seven healthy volunteers took etavopivat along with single doses of drugs like metformin, a statin, and …
Matched conditions: HEALTHY VOLUNTEERS SICKLE CELL DISEASE, THALASSEMIA
Phase: PHASE1 • Sponsor: Novo Nordisk A/S • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:29 UTC